320 related articles for article (PubMed ID: 30760220)
21. Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).
Milanini B; Ciccarelli N; Fabbiani M; Baldonero E; Limiti S; Gagliardini R; Borghetti A; D'Avino A; Mondi A; Colafigli M; Cauda R; Di Giambenedetto S
Clin Neuropsychol; 2016; 30(sup1):1457-1468. PubMed ID: 27180611
[TBL] [Abstract][Full Text] [Related]
22. Neurocognitive Impairment in a Chronically Well-Suppressed HIV-Infected Population: The Dutch TREVI Cohort Study.
van den Dries LWJ; Wagener MN; Jiskoot LC; Visser M; Robertson KR; Adriani KS; van Gorp ECM
AIDS Patient Care STDS; 2017 Aug; 31(8):329-334. PubMed ID: 28753395
[TBL] [Abstract][Full Text] [Related]
23. Montreal Cognitive Assessment Performance in HIV/AIDS: Impact of Systemic Factors.
Koenig N; Fujiwara E; Gill MJ; Power C
Can J Neurol Sci; 2016 Jan; 43(1):157-62. PubMed ID: 26635008
[TBL] [Abstract][Full Text] [Related]
24. Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable?
Parry S; Zetler S; Kentridge A; Petrak J; Barber T
AIDS Care; 2017 Oct; 29(10):1275-1279. PubMed ID: 28292203
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.
Troncoso FT; Conterno Lde O
Rev Soc Bras Med Trop; 2015; 48(4):390-8. PubMed ID: 26312927
[TBL] [Abstract][Full Text] [Related]
26. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.
Cross S; Önen N; Gase A; Overton ET; Ances BM
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1114-22. PubMed ID: 24114509
[TBL] [Abstract][Full Text] [Related]
27. Short Communication: Carotid Intima-Media Thickness Is Not Associated with Neurocognitive Impairment Among People Older than 50 Years With and Without HIV Infection from Thailand.
Hiransuthikul A; Chutinet A; Sakulrak S; Samajarn J; Vongsayan P; Kijpaisalratana N; Akarathanawat W; Apornpong T; Sangarlangkarn A; Gatechompol S; Han WM; Chattranukulchai P; Kerr S; Ruxrungtham K; Avihingsanon A
AIDS Res Hum Retroviruses; 2019; 35(11-12):1170-1173. PubMed ID: 31588776
[TBL] [Abstract][Full Text] [Related]
28. Validity of the International HIV dementia scale in Brazil.
Rodrigues RA; Oliveira RL; Grinsztejn B; Silva MT
Arq Neuropsiquiatr; 2013 Jun; 71(6):376-9. PubMed ID: 23828527
[TBL] [Abstract][Full Text] [Related]
29. Adding a brief self-report cognitive tool to the IHDS improves effectiveness of identifying patients with HIV-associated dementia in South Africa.
Gouse H; Casson-Crook M; Decloedt EH; Joska JA; Thomas KGF
J Neurovirol; 2017 Oct; 23(5):686-695. PubMed ID: 28748448
[TBL] [Abstract][Full Text] [Related]
30. Functional deficits and other psychiatric associations with abnormal scores on the Montreal Cognitive Assessment (MoCA) in older HIV-infected patients.
Bourgeois JA; John M; Zepf R; Greene M; Frankel S; Hessol NA
Int Psychogeriatr; 2020 Jan; 32(1):105-118. PubMed ID: 31014404
[TBL] [Abstract][Full Text] [Related]
31. Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
Ding Y; Lin H; Shen W; Wu Q; Gao M; He N
J Neuroimmune Pharmacol; 2017 Dec; 12(4):661-669. PubMed ID: 28470583
[TBL] [Abstract][Full Text] [Related]
32. Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: suggested solutions for resource-limited clinical settings.
Chan LG; Ho MJ; Lin YC; Ong Y; Wong CS
AIDS Res Ther; 2019 Apr; 16(1):9. PubMed ID: 30987670
[TBL] [Abstract][Full Text] [Related]
33. Utility of the Montreal Cognitive Assessment (MoCA) and its subset in HIV-associated neurocognitive disorder (HAND) screening.
Kim WJ; Ku NS; Lee YJ; Ahn JY; Kim SB; Ahn HW; Hong KW; Song JY; Cheong HJ; Kim WJ; Kim JM; Namkoong K; Choi JY; Kim E
J Psychosom Res; 2016 Jan; 80():53-7. PubMed ID: 26721548
[TBL] [Abstract][Full Text] [Related]
34. The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon.
Njamnshi AK; Djientcheu Vde P; Fonsah JY; Yepnjio FN; Njamnshi DM; Muna WE
J Acquir Immune Defic Syndr; 2008 Dec; 49(4):393-7. PubMed ID: 19186351
[TBL] [Abstract][Full Text] [Related]
35. Neurological manifestation with special reference to HIV-associated neurocognitive disorder (HAND) among people on anti-retroviral treatment in India.
Shaik RA; Holyachi S; Ahmad MS; Ahmad RK; Yusuf M; Khan M; Almutairi AB; Alghuyaythat WKZ
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6999-7004. PubMed ID: 34859862
[TBL] [Abstract][Full Text] [Related]
36. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
[TBL] [Abstract][Full Text] [Related]
37. Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.
Tymchuk S; Gomez D; Koenig N; Gill MJ; Fujiwara E; Power C
Can J Psychiatry; 2018 May; 63(5):329-336. PubMed ID: 29228820
[TBL] [Abstract][Full Text] [Related]
38. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.
de Almeida SM; Kamat R; Cherner M; Umlauf A; Ribeiro CE; de Pereira AP; Franklin D; Heaton RK; Ellis RJ
J Acquir Immune Defic Syndr; 2017 Mar; 74(3):332-338. PubMed ID: 27828876
[TBL] [Abstract][Full Text] [Related]
39. Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.
Choi Y; Townend J; Vincent T; Zaidi I; Sarge-Njie R; Jaye A; Clifford DB
J Neurovirol; 2011 Apr; 17(2):166-75. PubMed ID: 21424866
[TBL] [Abstract][Full Text] [Related]
40. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
